Forum on Innovation for Life Sciences
In honor of the Ningbo-Hangzhou Bay campus opening and our commitment to science and technology, a forum was held the day of the Ningbo site ceremony.
Nine speakers from academia and industry presented on topics covering novel and effective synthetic methodologies including chiral and non-chiral catalysis and fluorine chemistry, highly efficient total synthesis of complex natural products, automation of synthesis and its integration with bioassays, the discovery of new generation of drugs against cancer, autoimmune diseases and anemia and the importance of crystallization in late development.
These talks are representative of the current state-of-the-art of synthetic organic chemistry, crystallization technology, and drug discovery and development in the global academia and industry. The speakers also discussed the industry’s strategic thinking on how to transform fundamentally drug discovery and development performance, with case studies.
Speakers:
- Prof. Qilin Zhou, Nankai University
- Dr. Robert Geertman, Janssen Research and Development
- Dr. Michael Kress, Merck Sharp & Dohme
- Dr. Michael Varney, Genentech
- Dr. Stevan Djuric, AbbVie
- Dr. Sergii Pazenok, Bayer AG
- Dr. Helmut Haning, Bayer AG
- Dr. Peter Toogood, Lycera
- Prof. Darren Dixon, University of Oxford